SUMMARY An enzymatic kit method for the determination of plasma creatinine was optimised for use with a centrifugal analyser and its performance characteristics and practicability compared with an end point and a kinetic Jaffe-based method. The enzymatic method exhibited several advantages over Jaffe-based methods-namely, smaller sample size, rapid sample throughput (200 per hour), and improved specificity. Glucose, acetoacetate, and cefoxitin did not interfere with the enzymatic method, although bilirubin did cause a negative interference which depended on both creatinine and bilirubin concentrations. The enzymatic method has particular clinical application in neonates, diabetic ketotic patients, and those receiving cephalosporins.
Routine clinical biochemistry laboratories use several methods for the estimation of plasma and urinary concentrations of creatinine, most of which are based on the Jaffe reaction. There are major analytical problems associated with the use of the Jaffe reaction, however, in particular those relating to positive and negative interference by chromogens. More than 50 chromogenic interferents have been documented.' Many modifications of the original Jaffe method have been developed to reduce interference by such substances in plasma, but these vary in their degree of success.
Enzymatic methods for creatinine determination have been developed in an attempt to overcome some of the problems inherent in the Jaffe-based methods. The underlying test principle of a new commercially available method entails a series of sequential enzymemediated steps which result in the formation of hydrogen peroxide. A Trinder indicator system is the final step in the reaction sequence and is responsible for the formation of an intense red colour with a maximum absorbance at a wavelength of 510 nm. The reaction sequence is summarised in table 1. This method recently underwent a multicentre evaluation, in which 16 laboratories, using a variety of manual and mechanised methods and manufacturers' recommended protocols participated in the analytical evaluation. 2 In this report, the enzymatic method was specifically optimised for use on the Cobas Bio centrifugal Accepted for publication 16 December 1987 analyser (Roche Analytical Instruments, Nutley, New Jersey, USA) The analytical performance and practicability of the optimised method for routine use was assessed and compared with both a kinetic and end point Jaff-based method. The clinical utility of the method was also examined.
Material and methods

CREATININE METHODS
Enzymatic creatinine method Enzymatic creatinine analyses were performed using the Creatinine PAP (CREA) enzymatic colorimetric test kit (Boehringer Mannheim, Mannheim, West Germany; catalogue No 836 885).
Preparation and stability ofreagents Reagent 1 (buffer/enzymes/4-aminophenazone) Potassium phosphate buffer (22 ml) (100 mmol/l, pH 7.9) Enzymatic methodfor determining serum creatinine were added to the powdered contents ofphial 1, which contained creatinase, sarcosine oxidase, peroxidase and 4-aminophenazone. The resulting solution had the following composition: potassium phosphate buffer 100 mmol/l, pH 7-9; potassium hexacyanoferrate II 5 pmol/l; 2,4,6-tribromo-3-hydroxybenzoic acid 8-6 mmol/l; detergent 0-3%; 4-aminophenazone 0-8 mmol/l; creatinase >20 U/ml; sarcosine oxidase > 12 U/ml; peroxidase > 1 U/ml; ascorbate oxidase > 10 U/mi. This reagent is stable for two weeks at 40 to 12°C and for two days at 150 to 25°C. It must be stored protected from light. Reagent 2 (starter reagent, buffer/creatininase) Three reagent tablets were placed into the phial of buffer provided (phial 2) and allowed to dissolve. The resulting solution contained: potassium phosphate buffer 20 mmol/l pH 7 9; detergent 0-3%; creatininase > 164 U/ml. This solution is stable for two weeks at 4°t o 12°C and for two days at 150 to 25°C.
COMPARATIVE JAFFE-BASED METHODS
Endpoint Jafle (with dialysis) Creatinine analyses were also performed on a Technicon SMA 6/60 Autoanalyser (Technicon Instruments Corporation, Tarrytown, New York 10591, USA) by continuous flow analysis using an end point Jaffe-based method which incorporated a dialysis step. Colour produced was measured at a wavelength of 520 nm.
Kinetic Jaffe
Creatinine concentrations were also determined using the Beckman Astra 8 (Beckman Instruments Incorporated, Clinical Instruments Division, Brea, California 92621, USA). Colour production was measured at a wavelength of 520 nm 25-6 seconds after the sample had been introduced into the Jaffe reagent.
The quality control materials used in this study were Autonorm (Nycomed AS, Oslo, Norway) and Wellcontrol Abnormal Unassayed (Wellcome Diagnostics, Dartford prepared. Stock solution (5 p1 and 10 p1) were added to 1 ml aliquots of each of the three patient pools to give final concentrations of 2-5 and 5.0 mmol/l of acetoacetate, respectively. These concentrations approximated those readily attained in the plasma of patients with diabetic ketoacidosis. Bilirubin A stock solution (bilirubin, crystalline, from bovine gallstones, Sigma Chemical Company, St Louis, Missouri USA) of 10 mmol/l was prepared as follows: 117 mg of bilibrubin was dissolved in a solution of 2 ml of 01 M sodium carbonate (Ajax Chemical Co) and 1-5 ml of 0-1 M sodium hydroxide (Ajax). Once dissolved, this solution was made up to a volume of 20 ml with pooled plasma. This stock solution (10, 20 and 30 p1) was then added to I ml aliquots of each of the three patient pools. Final bilirubin concentrations was measured on a Unistat Bilirubinometer (Reichart-Jung) and gave values of 91, 179, and 267 pmol/l, respectively. Cefoxitin a cephalosporin antibiotic (0 9 mg and 1-8 mg) (cefoxitin sodium, Merck, Sharp, and Dohme, Grandville, New South Wales) were added to 2 mt aliquots of each of the three patient pools to give final cefoxitin concentrations of I and 2 mmol/l, respectively. These concentrations were consistent with therapeutic concentrations for this antibiotic.
Results
OPTIMISATION OF THE REACTION CONDITIONS FOR THE ENZYMATIC METHOD
The centrifugal analyser settings recommended by the reagent kit manufacturer are listed in table 2 (column A). These variables specify that the total reaction period should extend over eight minutes. This time comprises an initial four minutes of preincubation of reagent with sample, followed by a further four minutes of reaction period after addition of the starting reagent containing the limiting enzyme creatininase. Reaction readings are obtained at only two points, one at the beginning and one at the end of the four minute reaction period.
The test variables recommended by the manufacturer were initially evaluated. The four minute preincubation period was found to be necessary, as the 
The series of modifications described allowed the linear range of the method to be extended (to 1600 jmol/l), the reaction monitored at shorter reading intervals, and the total reaction time reduced by 90 seconds from eight minutes to six and a half minutes, with no difference in absolute creatinine concentration being observed with the shorter reaction time. The final optimised reaction conditions for the enzymatic creatinine method are listed in table 2 (column B).
PRECISION STUDIES
Intrarun and interrun precision data were obtained using five different samples, comprising three patient plasma pools containing low, moderate, and high concentrations of creatinine together with the two quality control materials routinely used in the laboratory of the authors (Autonorm and Wellcomtrol). For interrun precision studies, aliquots of the three patient pools were frozen at 0'C. The results obtained for intrarun and interrun precision studies are summarised in table 3. Coefficients of variation reported for patient samples were smaller than those reported for the quality control materials. This may be due to a combination of the different matrix of the quality control materials (lyophilised, and of bovine origin) and the contribution of operator error to imprecision, as quality control materials were reconstituted daily from lyophilised powder, often by different technicians.
ACCURACY
The accuracy of the optimised enzymatic method was determined by analysing 100 hospital patient samples in duplicate. The resulting mean value for each of the duplicate pairs was compared with the value obtained on the same samples using the Jaffe end point method on the Technicon SMA 6/60 and the kinetic Jaffe method on the Beckman Astra 8.
The results were assessed using linear regression and indicated that the creatinine concentrations reported using the enzymatic technique were not significantly different to those reported using Jaff&-based methods: enzymatic pmol/l (y) = 0-99 (end point Jaffe) x The results for glucose indicated that it does not interfere with the enzymatic test method. A small degree of positive interference (+ 19%) was observed at the lowest creatinine concentration with the kinetic Jaffe method, but higher concentrations of creatinine were unaffected by the two levels ofglucose tested. The results for acetoacetate showed that while the enzymatic method was unaffected by the addition of acetoacetate up to concentrations of 5 mmol/l, there was a considerable positive increase in the apparent creatinine concentration with the kinetic Jaffe method.
This increase in apparent creatinine concentration was both directly proportional to the acetoacetate concentration and inversely related to the creatinine concentration-that is, the positive effect being highest at the lowest concentration of creatinine.
Our results indicate that the kinetic Jaffe method is not affected by the addition of bilirubin, but with the enzymatic method there is a significant depression in the actual creatinine concentration following the addition of bilirubin. The magnitude of the decrease depends entirely on creatinine concentration and bilirubin concentrations. Bilirubin interference in peroxidase-coupled enzymatic assays entailing the spectrophotometric measurement of hydrogen peroxide has been reported previously.>" The mechanism by which bilirubin interference occurs has been explained by a combination of both spectral and chemical effects." Spectral interference results from overlap of the broad 460 nm absorption band of bilirubin with the absorption band of the Trinder chromophore. Chemical interference is postulated to be due to a peroxidase reaction intermediate reacting with bilirubin, thereby decreasing the final amount of chomophore formed. The latter interference can be eliminated by the addition of ferrocyanide to the reaction mixture, which stabilises the reaction intermediate. ' Crocker, Shephard, White gmol/l was assayed by the routine Beckman Astra. To assist the clinical decision on appropriate fluid management the specimen was reanalysed using the enzymatic method; a value of 81 pmol/l was found, suggesting normal renal function. The high concentration of acetoacetate in the patient's plasma had artefactually raised the apparent creatinine concentration to 235 pmol/1 when assayed by the kinetic Jaffe method. Case 2 An 18 month old infant presented with a three day history of persistent rhinorrhoea and modest anorexia, together with a 12 hour history ofhigh fever, irritability, episodic drowsiness and vomiting. Examination showed prominent neck stiffness and possibly slight dehydration. A presumptive diagnosis ofmeningitis was subsequently confirmed by examination of cerebrospinal fluid. The patient was given cephalosporin cefotaxime (500 mg intravenously) and intravenous fluids at half normal maintenance volume. Plasma electrolytes over the next 24 hours are shown in table 6 .
The admission hyponatraemia was thought to be Enzymatic methodfor determining serum creatinine 581 secondary to the syndrome of inappropriate antidiuretic hormone secretion, but the raised creatinine concentrations of 63, 137, 132 and 99 umol/l suggested pre-renal failure. The biochemistry laboratory was consulted and enzymatic creatinine determinations were performed on the two latest plasma samples. The results were found to be normal for an infant of this age (table 6), which allowed intravenous fluid administration to be continued.
PRACTICABILITY
The practicability of the enzyme-based method was also assessed. The assay is simple to perform, readily adaptable to the emergency or on-call situation, utilises a very small sample size (7 p1) and is rapid, being capable of analysing 200 samples perthour. A minor disadvantage of the method isits relatively high cost.
Discussion
The enzymatic method for creatinine evaluated in this study showed considerable improvement on the specificity of the existing Jaffe-based methods, although a problem still exists with interference from bilirubin. The modified enzymatic method was both precise and accurate, used a small sample size, and was capable of a rapid throughput of patient samples. We conclude that the enzymatic method is suitable as a routine diagnostic laboratory method for the measurement of plasma creatinine, particularly for diabetic ketotic patients, neonates, and patients receiving cephalosporins.
